Hartalega Holdings Berhad (5168.KL)
Kuala Lumpur, MY
Hartalega Holdings Berhad operates as an investment holding enterprise with a primary focus on the global manufacturing, distribution, and sale of latex and nitrile gloves. Its extensive market reach spans Malaysia, North America, Europe, various regions of Asia, Australia, South America, and the Middle East. Additionally, the company diversifies its operations through property leasing, pioneering research and development in automation systems, and the international export and trade of medical supplies. Its product offerings cater to a wide array of industries, including healthcare, dentistry, food processing, industrial use, veterinary care, and the spa and beauty salon sectors. The company was established in 1988 and maintains its headquarters in Kuala Lumpur, Malaysia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +17.39% | +8.00% | +50.00% | +18.42% | +36.36% | -31.82% | -39.46% | -85.83% | -32.16% | +748.15% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | 0 |
| Hold | 8 | -2 |
| Sell | 3 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-17.4% Q1'26: -15.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+38.5% ★ Q1'26: +183.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+11.1% ★ Q1'26: +14.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+5.5% Q1'26: +9.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+3.1% Q1'26: +4.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.1% ★ Q1'26: -0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.03× ★ Q1'26: 0.03× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 17 Rev. Ana. 17 EPS Ana. |
Mar 2027 16 Rev. Ana. 15 EPS Ana. |
Mar 2028 10 Rev. Ana. 7 EPS Ana. |
Mar 2029 11 Rev. Ana. 10 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.15B
est: 1.14B (+0.3%)
|
1.50B
est: 1.50B (-0.1%)
|
1.82B
est: 1.80B (+1.3%)
|
2.41B
est: 2.47B (-2.7%)
|
2.83B
est: 2.89B (-2.0%)
|
2.92B
est: 3.03B (-3.4%)
|
6.70B
est: 7.07B (-5.2%)
|
7.89B
est: 7.96B (-0.9%)
|
2.41B
est: 2.27B (+6.2%)
|
1.84B
est: 1.95B (-5.6%)
|
2.59B
est: 2.56B (+1.0%)
|
2.24B
2.08B – 2.75B
-12.6% YoY
|
2.68B
2.24B – 3.11B
+19.6% YoY
|
2.75B
2.29B – 3.19B
+2.6% YoY
|
2.91B
2.43B – 3.38B
+5.9% YoY
|
| EBITDA |
322.87M
est: 309.42M (+4.3%)
|
387.89M
est: 406.33M (-4.5%)
|
420.66M
est: 487.03M (-13.6%)
|
622.77M
est: 669.90M (-7.0%)
|
665.43M
est: 781.77M (-14.9%)
|
691.54M
est: 820.32M (-15.7%)
|
3.96B
est: 1.91B (+106.7%)
|
4.79B
est: 2.16B (+122.3%)
|
-43.79M
est: 614.87M (-107.1%)
|
178.16M
est: 527.70M (-66.2%)
|
200.67M
est: 458.70M (-56.3%)
|
400.77M
371.93M – 493.24M
-12.6% YoY
|
479.46M
400.57M – 556.74M
+19.6% YoY
|
492.04M
411.08M – 571.35M
+2.6% YoY
|
521.29M
435.51M – 605.32M
+5.9% YoY
|
| EBIT |
276.99M
est: 255.15M (+8.6%)
|
317.25M
est: 335.05M (-5.3%)
|
350.00M
est: 401.60M (-12.8%)
|
534.35M
est: 552.40M (-3.3%)
|
561.45M
est: 644.64M (-12.9%)
|
566.22M
est: 676.43M (-16.3%)
|
3.82B
est: 1.58B (+141.9%)
|
4.64B
est: 1.78B (+161.1%)
|
-206.82M
est: 507.02M (-140.8%)
|
46.11M
est: 435.14M (-89.4%)
|
50.01M
est: 308.29M (-83.8%)
|
269.35M
249.97M – 331.50M
-12.6% YoY
|
322.24M
269.22M – 374.18M
+19.6% YoY
|
330.70M
276.28M – 384.00M
+2.6% YoY
|
350.36M
292.70M – 406.83M
+5.9% YoY
|
| Net Income |
209.73M
est: 228.72M (-8.3%)
|
257.43M
est: 284.76M (-9.6%)
|
283.00M
est: 297.82M (-5.0%)
|
438.92M
est: 446.60M (-1.7%)
|
455.18M
est: 507.15M (-10.2%)
|
433.62M
est: 467.13M (-7.2%)
|
2.89B
est: 2.99B (-3.5%)
|
3.23B
est: 3.28B (-1.3%)
|
-235.14M
est: 70.00M (-435.9%)
|
12.50M
est: 43.96M (-71.6%)
|
74.54M
est: 77.70M (-4.1%)
|
89.30M
52.63M – 202.78M
+14.9% YoY
|
154.57M
114.69M – 219.87M
+73.1% YoY
|
173.53M
136.41M – 209.90M
+12.3% YoY
|
184.35M
144.91M – 222.98M
+6.2% YoY
|
| SGA |
64.66M
est: 71.04M (-9.0%)
|
85.76M
est: 93.29M (-8.1%)
|
103.94M
est: 111.81M (-7.0%)
|
126.89M
est: 153.80M (-17.5%)
|
139.46M
est: 179.48M (-22.3%)
|
147.74M
est: 188.33M (-21.6%)
|
293.66M
est: 439.62M (-33.2%)
|
225.05M
est: 495.04M (-54.5%)
|
161.76M
est: 141.17M (+14.6%)
|
179.39M
est: 121.15M (+48.1%)
|
191.07M
est: 136.82M (+39.7%)
|
119.54M
110.94M – 147.12M
-12.6% YoY
|
143.01M
119.48M – 166.06M
+19.6% YoY
|
146.77M
122.62M – 170.42M
+2.6% YoY
|
155.49M
129.91M – 180.55M
+5.9% YoY
|
| EPS |
0.07
est: 0.07 (+0.6%)
|
0.08
est: 0.08 (-5.9%)
|
0.09
est: 0.09 (-1.2%)
|
0.13
est: 0.13 (-0.6%)
|
0.14
est: 0.15 (-5.7%)
|
0.13
est: 0.14 (-5.0%)
|
0.84
est: 0.88 (-4.1%)
|
0.95
est: 0.96 (-1.0%)
|
-0.07
est: 0.02 (-435.6%)
|
0.00
est: 0.01 (-71.3%)
|
0.02
est: 0.02 (-4.3%)
|
0.03
0.02 – 0.06
+14.9% YoY
|
0.05
0.03 – 0.06
+73.1% YoY
|
0.05
0.04 – 0.06
+12.3% YoY
|
0.05
0.04 – 0.07
+6.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.03% | 24.3K | 0.74% |
| 2 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.02% | 89.5K | 0.72% |
| 3 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.02% | 73.4K | 0.74% |
| 4 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.02% | 106.3K | 0.55% |
| 5 | Avantis Emerging Markets Value ETF AVES | 0.01% | 193.7K | 0.36% |
| 6 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.01% | 52.6K | 0.33% |
| 7 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.71M | 0.06% |
| 8 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.01% | 22.7K | 0.35% |
| 9 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 177.6K | 0.46% |
| 10 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 26.4K | 0.56% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kam Kuan | Executive Chairman | 192.0K | male |
| Mun Keng Kuan | Chief Business Officer & Executive Director | 145.0K | male |
| Mun Leong Kuan | Chief Executive Officer & Executive Director | 144.0K | male |
| Ming Siang Lee | Chief Strategy Officer | — | male |
| Sheetal Sharma | Head of Internal Audit Department | — | female |
| Siew Fei Yoon | Chief Human Resources Officer | — | male |
| Eu Jin Kuan | Chief Operating Officer | — | male |
| Vin Seung Kuan | Chief Corporation Communications Officer | — | male |
| Fook Chuan Lai | Head Scientist of Innovation | — | — |
| Kean Wooi Loh | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 5168.KL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
